首页> 外文期刊>Journal of drug targeting >Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
【24h】

Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.

机译:口服给予产乳酸布鲁氏菌L7 / L12抗原的乳酸乳球菌后,小鼠受到部分保护。

获取原文
获取原文并翻译 | 示例
           

摘要

The Brucella abortus ribosomal protein L7/L12 is an immunodominant antigen and an interesting candidate for the development of oral live vaccines against brucellosis. Here, a recombinant Lactococcus lactis strain producing L7/L12 under the control of nisin inducible promoter was orally administered to BALB/c mice. Significant levels of anti-L7/L12 specific IgA detected in feces revealed an induced local humoral immune response. However, serum analysis did not reveal any anti-L7/L12 antibodies suggesting the absence of a systemic response. Nevertheless, the vaccinated mice showed a partial protective immunity against B. abortus virulent strain (S2308) challenged by intraperitoneal inoculation.
机译:流产布鲁氏菌核糖体蛋白L7 / L12是一种免疫优势抗原,是开发抗布鲁氏菌病口服活疫苗的有趣候选物。在此,将在乳链菌肽诱导型启动子的控制下产生L7 / L12的重组乳酸乳球菌菌株口服给予BALB / c小鼠。粪便中检测到的抗L7 / L12特异性IgA的显着水平显示了诱导的局部体液免疫反应。但是,血清分析未发现任何抗L7 / L12抗体,提示缺乏全身应答。然而,接种疫苗的小鼠表现出针对腹膜内接种挑战的流产双歧杆菌强毒株(S2308)的部分保护性免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号